Drug Research
Lonza to Partner with Capricor Therapeutics for the Development of Duchenne Muscular Dystrophy Cell Therapy
Lonza and Capricor Therapeutics, a US-based clinical-stage biotechnology company, announced on Jan. 12, 2020 that they are entering into an agreement for the development of CAP-1002, Capricor's clinical cell therapy that uses allogeneic cardiosphere-derived cells technology for the treatment...
News
Bharat Biotech signs agreement with Precisa Medicamentos to supply Covaxin to Brazil
Bharat Biotech announced that it has signed an agreement with Precisa Medicamentos for the supplies of COVAXIN™ to Brazil.
A team from Precisa Medicamentos has visited the Bharat Biotech facility last week to discuss potential export possibilities of COVAXIN™, India’s...
Drug Research
US FDA grants emergency use authorization to Quanterixs Simoa SARS-CoV-2 N protein antigen test
Quanterix Corporation, a company digitizing biomarker analysis to advance the science of precision health, announced that the Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for its Simoa SARS-CoV-2 N Protein Antigen Test that can...
News
Softbox appoints new Technical Solutions Specialist to further extend technical support to customers
Softbox, a leading global innovator and provider of passive temperature controlled packaging solutions for the pharmaceutical, life science and cold chain logistics industries, has announced the appointment of Matthew Tomkinson as a Technical Solutions Specialist.
Matt joins Softbox’s Technical Solutions...
Clinical Trials
NeuroRx, Relief, and Quantum Leap announce the inclusion of ZYESAMI in the I-SPY COVID-19 Trial
NeuroRx, Inc. and RELIEF THERAPEUTICS Holding AG, and the Quantum Leap Healthcare Collaborative of San Francisco announce that NeuroRx and QLHC have signed a Clinical Trial Participation Agreement for the inclusion of ZYESAMI™ in the I-SPY COVID-19 Clinical Trial....
News
UNICEF, WHO, IFRC and MSF announce the establishment of a global Ebola vaccine stockpile
The four leading international health and humanitarian organizations announced today the establishment of a global Ebola vaccine stockpile to ensure outbreak response.
The effort to establish the stockpile was led by the International Coordinating Group (ICG) on Vaccine Provision, which...
Drug Research
Abzena announces opening of new biologics GMP manufacturing site with up to 12 X 2000L bioreactors
Abzena, a Global Partner Research Organization for integrated bench to market solutions for biologics and bioconjugates, has announced the addition of a 6th Global site that will augment cGMP manufacturing capacity for mammalian biologics. This expansion is driven by...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read












